Figure 2

OPLS-DA score plots based on the data from (A,C) LC-(+)ESI-MS and (B,D) LC-(−)ESI-MS of ESCC patients and healthy controls.
, early-stage ESCC patients (T1–2);
, advanced-stage ESCC patients (T3–4); and
, controls.

OPLS-DA score plots based on the data from (A,C) LC-(+)ESI-MS and (B,D) LC-(−)ESI-MS of ESCC patients and healthy controls.
, early-stage ESCC patients (T1–2);
, advanced-stage ESCC patients (T3–4); and
, controls.